Omnipod 5 with Dexcom G7 Integration is Here!

Hosted by Nancy Hanna

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.

Recorded live at the ADA Conference in Orlando, Florida. Nancy Hanna is joined by Dr. Pablo Mora who is an Endocrinologist at the North Texas Diabetes & Endocrinology Medical Center in Plano, Texas. During this episode, Nancy and Dr. Mora discuss the integration between the Omnipod 5 Automated Insulin Delivery System and the Dexcom G7 CGM. Dr. Mora discusses his experience as part of the Limited Market Release for Omnipod 5 with Dexcom G7 and provides insights into the benefit of this integration for his patients with type 1 diabetes.

Listen to learn how Dr. Mora has leveraged this technology to simplify diabetes management with his patients!

Time stamps

6:28 – Omnipod 5 integration with Dexcom G7 has arrived in limited market release. Hear from Dr. Mora how it provides more options for his patients.
13:00 – Hear how Dr. Mora matches his patients’ needs to the different solutions Omnipod 5 offers
17:38 – Learn about the impact on patients because Omnipod 5 is a covered Pharmacy benefit vs durable medical equipment

 

See more episodes
This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.